Heavy Metal Toxicity Clinical Presentation
- Author: Samara Soghoian, MD, MA; Chief Editor: Asim Tarabar, MD more...
History
- A history of exposure is the most critical aspect of diagnosing heavy metal toxicity. A complete history includes questions about potential occupational exposures, hobbies, recreational activities, and potential environmental exposure.
- A complete dietary history should be taken, especially the ingestion of fish, seafood, and seaweed products since these will frequently be implicated as dietary sources of organic (and relatively nontoxic) mercury, arsenic, or both. The timing of ingestion relative to the collection of urine samples is critical to interpreting the results.
- Herbal medications and dietary supplements are also potential sources of heavy metal exposure. Many Ayurvedic and Chinese patent medicines contain heavy metals.
- Most acute presentations of heavy metal toxicity involve industrial exposure.
- The ingestion of nonfood items such as paint chips, toys, and ballistic devices has also been implicated as the source of metal exposure in several cases.
- Retained lead shot may ultimately lead to toxicity as well, although generally the shot must be bathed in relatively acidic body compartments like the stomach or joints in order for significant absorption of metal ions to occur.
Physical
- General: The physical examination of patients with suspected metal toxicity should focus on the most commonly involved organ systems: the nervous, gastrointestinal, hematologic,[7] renal, and integumentary systems. See the Table for common presentations of acute and chronic exposures to specific metals.
- Nausea, persistent vomiting, diarrhea, and abdominal pain are the hallmark of most acute metal ingestions. Dehydration is common. Metal salts are generally corrosive.
- Encephalopathy, cardiomyopathy, dysrhythmias, acute tubular necrosis, and metabolic acidosis are also commonly seen with acute, high-dose exposures to most metals.
- Patients with chronic metal toxicity tend to have more prominent involvement of the CNS and PNS, although encephalopathy and peripheral neuropathies may occur within a few hours to days of acute high-dose exposure.
- A classic presentation of chronic metal exposure includes anemia, Mees lines (horizontal hypopigmented lines across all nails), and subtle neurologic findings. These findings should prompt suspicion of heavy metal toxicity in any patient regardless of chief complaint.
- Because it is relatively common, any combination of GI complaints, neurologic dysfunction, and anemia should prompt a search for lead toxicity.
Schwartz BS, Hu H. Adult lead exposure: time for change. Environ Health Perspect. Mar 2007;115(3):451-4. [Medline].
Bowler RM, Roels HA, Nakagawa S, et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med. Mar 2007;64(3):167-77. [Medline].
Roney N, Osier M, Paikoff SJ, et al. ATSDR evaluation of the health effects of zinc and relevance to public health. Toxicol Ind Health. Nov 2006;22(10):423-93. [Medline].
Parry J. Metal smelting plants poison hundreds of Chinese children. BMJ. Aug 24 2009;339:b3433. [Medline].
Watts J. Lead poisoning cases spark riots in China. Lancet. Sep 12 2009;374(9693):868. [Medline].
Hornung RW, Lanphear BP, Dietrich KN. Age of greatest susceptibility to childhood lead exposure: a new statistical approach. Environ Health Perspect. Aug 2009;117(8):1309-12. [Medline].
Prozialeck WC, Edwards JR, Nebert DW, et al. The vascular system as a target of metal toxicity. Toxicol Sci. Apr 2008;102(2):207-18. [Medline].
[Guideline] Caravati EM, Erdman AR, Christianson G, Nelson LS, Woolf AD, Booze LL, et al. Elemental mercury exposure: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). Jan 2008;46(1):1-21. [Medline]. [Full Text].
[Guideline] Manoguerra AS, Erdman AR, Booze LL, Christianson G, Wax PM, Scharman EJ, et al. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2005;43(6):553-70. [Medline]. [Full Text].
Ball H. Arsenic Poisoning and Napoleon's Death. New Scientist. October 1982;101-104.
Ellenhorn MJ. Ellenhorn's Medical Toxicology. 2nd ed. Williams & Wilkins: 1997:1532-1613.
Ford M. Arsenic. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th ed. McGraw-Hill; 2006:1251-1264.
Henretig FM. Lead. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th ed. McGraw-Hill; 2006:1308-1324.
Kaye P, Young H, O'Sullivan I. Metal fume fever: a case report and review of the literature. Emerg Med J. May 2002;19(3):268-9. [Medline].
Meulenbelt J, van Zoelen GA, Vries de I. Cadmium intoxication: features and management. J Toxicol Clin Toxicol. Apr 2001;39:223-226.
Petersdorf RG, Martin JB, Fauci AS, et al. Harrison's Principals of Internal Medicine. Vol 2. 12th ed. McGraw-Hill; 1991:2182-7.
Sue YJ. Mercury. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th ed. McGraw-Hill; 2006:1334-1344.
Tintinalli JE, Ruiz E, Krome RL. Emergency Medicine: A Comprehensive Study Guide. 4th ed. McGraw-Hill; 1996:833-41.
| Metal | Acute | Chronic | Toxic Concentration | Treatment |
| Arsenic | Nausea, vomiting, "rice-water" diarrhea, encephalopathy, MODS, LoQTS, painful neuropathy | Diabetes, hypopigmentation/ hyperkeratosis, cancer: lung, bladder, skin, encephalopathy | 24-h urine: ≥50 µg/L urine, or 100 µg/g creatinine | BAL (acute, symptomatic) Succimer DMPS (Europe) |
| Bismuth | Renal failure; acute tubular necrosis | Diffuse myoclonic encephalopathy | No clear reference standard | * |
| Cadmium | Pneumonitis (oxide fumes) | Proteinuria, lung cancer, osteomalacia | Proteinuria and/or ≥15 µg/ g creatinine | * |
| Chromium | GI hemorrhage, hemolysis, acute renal failure (Cr6+ ingestion) | Pulmonary fibrosis, lung cancer (inhalation) | No clear reference standard | NAC (experimental) |
| Cobalt | Beer drinker’s (dilated) cardiomyopathy | Pneumoconiosis (inhaled); goiter | Normal excretion: 0.1-1.2 µg/L (serum) 0.1-2.2 µg/L (urine) | NAC CaNa2 EDTA |
| Copper | Blue vomitus, GI irritation/ hemorrhage, hemolysis, MODS (ingested); MFF (inhaled) | vineyard sprayer’s lung (inhaled); Wilson disease (hepatic and basal ganglia degeneration) | Normal excretion: 25 µg/24 h (urine) | BAL D-Penicillamine Succimer |
| Iron | Vomiting, GI hemorrhage, cardiac depression, metabolic acidosis | Hepatic cirrhosis | Nontoxic: < 300 µg/dL Severe: >500 µg/dL | Deferoxamine |
| Lead | Nausea, vomiting, encephalopathy (headache, seizures, ataxia, obtundation) | Encephalopathy, anemia, abdominal pain, nephropathy, foot-drop/ wrist-drop | Pediatric: symptoms or [Pb] ≥45 µ/dL (blood); Adult: symptoms or [Pb] ≥70 µ/dL[1] | BAL CaNa2 EDTA Succimer |
| Manganese | MFF (inhaled) | Parkinson-like syndrome, respiratory, neuropsychiatric[2] | No clear reference standard | * |
| Mercury | Elemental (inhaled): fever, vomiting, diarrhea, ALI; Inorganic salts (ingestion): caustic gastroenteritis | Nausea, metallic taste, gingivo-stomatitis, tremor, neurasthenia, nephrotic syndrome; hypersensitivity (Pink disease) | Background exposure "normal" limits: 10 µg/L (whole blood); 20 µg/L (24-h urine) | BAL Succimer DMPS (Europe) |
| Nickel | Dermatitis; nickel carbonyl: myocarditis, ALI, encephalopathy | Occupational (inhaled): pulmonary fibrosis, reduced sperm count, nasopharyngeal tumors | Excessive exposure: ≥8 µg/L (blood) Severe poisoning: ≥500 µg/L (8-h urine) | * |
| Selenium | Caustic burns, pneumonitis, hypotension | Brittle hair and nails, red skin, paresthesia, hemiplegia | Mild toxicity: [Se] >1mg/L (serum); Serious: >2 mg/L | * |
| Silver | Very high doses: hemorrhage, bone marrow suppression, pulmonary edema, hepatorenal necrosis | Argyria: blue-grey discoloration of skin, nails, mucosae | Asymptomatic workers have mean [Ag] of 11 µg/L (serum) and 2.6 µg/L (spot urine) | Selenium, vitamin E (experimental) |
| Thallium | Early: Vomiting, diarrhea, painful neuropathy, coma, autonomic instability, MODS | Late findings: Alopecia, Mees lines, residual neurologic symptoms | Toxic: >3 µg/L (blood) | MDAC Prussian blue |
| Zinc[3] | MFF (oxide fumes); vomiting, diarrhea, abdominal pain (ingestion) | Copper deficiency: anemia, neurologic degeneration, osteoporosis | Normal range: 0.6-1.1 mg/L (plasma) 10-14 mg/L (red cells) | * |
| *No accepted chelation regimen; contact a medical toxicologist regarding treatment plan. MODS, multi-organ dysfunction syndrome; LoQTS, long QT syndrome; ALI, acute lung injury; ATN, acute tubular necrosis; ARF, acute renal failure; DMPS, 2,3-dimercapto-1-propane-sulfonic acid; CaNa2 EDTA, edetate calcium disodium; MDAC, multi-dose activated charcoal; NAC, N -acetylcysteine. | ||||
Print
